Inhibitory Effects of Castration in an Orthotopic Model of Androgen-Independent Prostate Cancer Can Be Mimicked and Enhanced by Angiogenesis Inhibition
Purpose: Today, the most important treatment of advanced prostate cancer is castration; unfortunately, however, the long-term effect of this therapy is insufficient. Recent studies suggest that castration-induced prostate involution could be caused by primary effects in the prostate vasculature; the...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2006-12, Vol.12 (24), p.7431-7436 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose: Today, the most important treatment of advanced prostate cancer is castration; unfortunately, however, the long-term effect
of this therapy is insufficient. Recent studies suggest that castration-induced prostate involution could be caused by primary
effects in the prostate vasculature; therefore, we examined if antivascular treatments could mimic the effects of castration.
Experimental Design: Androgen-independent AT-1 prostate cancer cells were grown inside the ventral prostate in adult rats. Tumor-bearing animals
were treated with an inhibitor of vascular endothelial growth factor receptor 2 and epidermal growth factor receptor signaling,
N -(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine (ZD6474, AstraZeneca, Södertälje,
Sweden), and short-term effects (after 3 days) were compared with those induced by castration.
Results: Castration caused decreased vascular density in the normal tissue surrounding the tumor and consequently increased tumor
hypoxia and apoptosis, and moderately decreased tumor growth. ZD6474 treatment resulted in decreased tumor vascular density
accompanied by increased tumor hypoxia, apoptosis, and decreased tumor growth, suggesting that castration and antiangiogenic
therapy work through similar mechanisms. Interestingly, castration or ZD6474 alone worked by reducing vascular density in
the surrounding normal tissue and ZD6474 also in the tumor. Combined treatment with castration + ZD6474 was more effective
than castration and ZD6474 alone in inducing tumor hypoxia, apoptosis, necrosis, and decreasing tumor vascular density.
Conclusion: These findings show that a drug that targets the vasculature in the tumor and in the surrounding ventral prostate lobe could
mimic and even enhance the effects of castration. Our present findings thus suggest that castration + ZD6474 could be a particularly
effective way to treat prostate tumors. |
---|---|
ISSN: | 1078-0432 1557-3265 |
DOI: | 10.1158/1078-0432.CCR-06-1895 |